Haemonetics - 34 Year Stock Split History | HAE

Stock split history for Haemonetics since 1991. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Haemonetics Annual Stock Splits
Haemonetics Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.139B $1.309B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.702B 27.74
Boston Scientific (BSX) United States $154.217B 38.61
Stryker (SYK) United States $145.561B 30.44
EssilorLuxottica (ESLOY) France $133.244B 0.00
Medtronic (MDT) Ireland $107.028B 15.63
Lonza Group Ag (LZAGY) Switzerland $52.631B 0.00
Haleon (HLN) United Kingdom $47.943B 27.26
ResMed (RMD) United States $35.287B 26.50
GE HealthCare Technologies (GEHC) United States $31.763B 15.08
Agilent Technologies (A) United States $30.897B 20.41
Terumo (TRUMY) Japan $29.152B 0.00
Koninklijke Philips (PHG) Netherlands $24.100B 17.21
Insulet (PODD) United States $18.209B 77.71
Zimmer Biomet Holdings (ZBH) United States $17.901B 11.50
Baxter (BAX) United States $15.608B 11.66
Smith & Nephew SNATS (SNN) United Kingdom $12.425B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $7.970B 0.00
Lantheus Holdings (LNTH) United States $7.395B 18.18
Bio-Rad Laboratories (BIO) United States $6.728B 22.75
Prestige Consumer Healthcare (PBH) United States $4.111B 19.62
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Perrigo (PRGO) Ireland $3.444B 9.86
ICU Medical (ICUI) United States $3.347B 28.51
Envista Holdings (NVST) United States $2.876B 23.90
GN Store Nord (GNNDY) Denmark $2.071B 17.15
QuidelOrtho (QDEL) United States $1.868B 15.64
LeMaitre Vascular (LMAT) United States $1.817B 40.63
AtriCure (ATRC) United States $1.439B 0.00
Green Thumb Industries (GTBIF) United States $1.359B 21.40
Neogen (NEOG) United States $1.224B 15.67
AdaptHealth (AHCO) United States $1.173B 11.30
Kestra Medical Technologies (KMTS) United States $1.159B 0.00
BioLife Solutions (BLFS) United States $1.150B 0.00
InMode (INMD) Israel $0.991B 9.08
Phibro Animal Health (PAHC) United States $0.791B 12.13
Evolus (EOLS) United States $0.774B 0.00
Owens & Minor (OMI) United States $0.632B 5.38
Curaleaf Holdings (CURLF) Canada $0.618B 0.00
CeriBell (CBLL) United States $0.583B 0.00
Valneva SE (VALN) France $0.557B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.539B 0.00
Capricor Therapeutics (CAPR) United States $0.470B 0.00
Tilray Brands (TLRY) Canada $0.442B 0.00
Cresco Labs (CRLBF) United States $0.437B 0.00
Omeros (OMER) United States $0.397B 0.00
Surmodics (SRDX) United States $0.386B 0.00
SNDL (SNDL) Canada $0.355B 0.00
VAREX IMAGING (VREX) United States $0.348B 15.09
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Verano Holdings (VRNOF) United States $0.312B 0.00
Viemed Healthcare (VMD) United States $0.290B 26.18
Sanara MedTech (SMTI) United States $0.288B 0.00
Aurora Cannabis (ACB) Canada $0.265B 47.20
Sanuwave Health (SNWV) United States $0.265B 0.00
Cerus (CERS) United States $0.249B 0.00
ZimVie (ZIMV) United States $0.247B 14.80
Canopy Growth (CGC) Canada $0.234B 0.00
Quanterix (QTRX) United States $0.225B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
High Tide (HITI) Canada $0.192B 0.00
Biote (BTMD) United States $0.178B 4.06
Utah Medical Products (UTMD) United States $0.172B 13.83
TriSalus Life Sciences (TLSI) United States $0.165B 0.00
Brainsway (BWAY) Israel $0.164B 51.24
Organigram Global (OGI) Canada $0.149B 0.00
FitLife Brands (FTLF) United States $0.145B 17.91
Jin Medical (ZJYL) China $0.125B 0.00
TerrAscend (TSNDF) Canada $0.118B 0.00
Exagen (XGN) United States $0.113B 0.00
Agape ATP (ATPC) $0.105B 0.00
MacroGenics (MGNX) United States $0.103B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 0.00
Quipt Home Medical (QIPT) United States $0.093B 0.00
Jushi Holdings (JUSHF) United States $0.081B 0.00
Fonar (FONR) United States $0.076B 10.61
Veru (VERU) United States $0.075B 0.00
InterCure (INCR) Israel $0.072B 0.00
Zynex (ZYXI) United States $0.064B 0.00
Cytosorbents (CTSO) United States $0.057B 0.00
United Health Products (UEEC) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Apyx Medical (APYX) United States $0.044B 0.00
Modular Medical (MODD) United States $0.041B 0.00
Rockwell Medical (RMTI) United States $0.041B 59.50
Safety Shot (SHOT) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 11.31
Nephros (NEPH) United States $0.020B 0.00
INLIF (INLF) $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Innovative Eyewear (LUCY) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00